Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 83

1.

Should we use proton pump inhibitors as an add-on treatment in hereditary hemochromatosis?

Kani HT, Gündüz F.

Turk J Gastroenterol. 2018 Mar;29(2):254-255. doi: 10.5152/tjg.2018.17713. No abstract available.

PMID:
29749343
2.

Haemochromatosis: Pathophysiology and the red blood cell1.

Richardson KJ, McNamee AP, Simmonds MJ.

Clin Hemorheol Microcirc. 2018;69(1-2):295-304. doi: 10.3233/CH-189128.

PMID:
29660923
3.

Fatal Cardiac Hemochromatosis in a Patient with Hereditary Spherocytosis.

Fujino T, Inoue S, Katsuki S, Higo T, Ide T, Oda Y, Tsutsui H.

Int Heart J. 2018 Mar 30;59(2):427-430. doi: 10.1536/ihj.17-160. Epub 2018 Mar 20.

4.

Do pregnancies reduce iron overload in HFE hemochromatosis women? results from an observational prospective study.

Scotet V, Saliou P, Uguen M, L'Hostis C, Merour MC, Triponey C, Chanu B, Nousbaum JB, Le Gac G, Ferec C.

BMC Pregnancy Childbirth. 2018 Feb 17;18(1):53. doi: 10.1186/s12884-018-1684-6.

5.

Reversal of end-stage heart failure in juvenile hemochromatosis with iron chelation therapy: a case report.

Cooray SD, Heerasing NM, Selkrig LA, Subramaniam VN, Hamblin PS, McDonald CJ, McLean CA, McNamara E, Leet AS, Roberts SK.

J Med Case Rep. 2018 Jan 26;12(1):18. doi: 10.1186/s13256-017-1526-6.

6.

Disparate clinical findings in monochorionic twins with neonatal hemochromatosis.

Midorikawa H, Mizuochi T, Okada JI, Hisano T.

Pediatr Int. 2017 Nov;59(11):1215-1216. doi: 10.1111/ped.13421. No abstract available.

PMID:
29359379
7.

Inherited haemochromatosis with C282Y mutation in a patient with alpha-thalassaemia: a treatment dilemma.

Al Qasem MA, Hanna F, Vithanarachchi US, Khalafallah AA.

BMJ Case Rep. 2018 Jan 4;2018. pii: bcr-2017-222700. doi: 10.1136/bcr-2017-222700.

PMID:
29301806
8.

Common founder effects of hereditary hemochromatosis, Wilson´s disease, the long QT syndrome and autosomal recessive deafness caused by two novel mutations in the WHRN and TMC1 genes.

Olsson KS, Wålinder O, Jansson U, Wilbe M, Bondeson ML, Stattin EL, Raha-Chowdhury R, Williams R.

Hereditas. 2017 Dec 19;154:16. doi: 10.1186/s41065-017-0052-2. eCollection 2017.

9.

Autopsy relevance determining hemochromatosis: Case report.

Chmieliauskas S, Banionis D, Laima S, Andriuskeviciute G, Mazeikiene S, Stasiuniene J, Jasulaitis A, Jarmalaite S.

Medicine (Baltimore). 2017 Dec;96(49):e8788. doi: 10.1097/MD.0000000000008788.

10.

Comment on: Hereditary haemochromatosis arthropathy and Doppler ultrasound findings of synovitis: reply.

Oke AR, Wong E, Young-Min S.

Rheumatology (Oxford). 2018 Apr 1;57(4):766-767. doi: 10.1093/rheumatology/kex437. No abstract available.

PMID:
29228396
11.

Comment on: Hereditary hemochromatosis arthropathy and Doppler ultrasound findings of synovitis.

Parperis K.

Rheumatology (Oxford). 2018 Apr 1;57(4):765-766. doi: 10.1093/rheumatology/kex436. No abstract available.

PMID:
29228359
12.

Genetic hemochromatosis: Pathophysiology, diagnostic and therapeutic management.

Brissot P, Cavey T, Ropert M, Guggenbuhl P, Loréal O.

Presse Med. 2017 Dec;46(12 Pt 2):e288-e295. doi: 10.1016/j.lpm.2017.05.037. Epub 2017 Nov 20. Review.

PMID:
29158016
13.

Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.

Majore S, Bonaccorsi di Patti MC, Valiante M, Polticelli F, Cortese A, Di Bartolomeo S, De Bernardo C, De Muro M, Faienza F, Radio FC, Grammatico P, Musci G.

Biochim Biophys Acta. 2018 Feb;1864(2):464-470. doi: 10.1016/j.bbadis.2017.11.006. Epub 2017 Nov 14.

PMID:
29154924
14.

The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Kawabata H.

Int J Hematol. 2018 Jan;107(1):31-43. doi: 10.1007/s12185-017-2365-3. Epub 2017 Nov 13. Review.

PMID:
29134618
15.

Diagnostic value of targeted next-generation sequencing in suspected hemochromatosis patients with a single copy of the HFE p.Cys282Tyr causative allele.

Uguen K, Scotet V, Ka C, Gourlaouen I, L'hostis C, Merour MC, Cuppens T, Ferec C, Le Gac G.

Am J Hematol. 2017 Dec;92(12):E664-E666. doi: 10.1002/ajh.24912. Epub 2017 Oct 23. No abstract available.

PMID:
29084376
16.

Ultrasound verified inflammation and structural damage in patients with hereditary haemochromatosis-related arthropathy.

Dejaco C, Stadlmayr A, Duftner C, Trimmel V, Husic R, Krones E, Zandieh S, Husar-Memmer E, Zollner G, Hermann J, Gretler J, Lackner A, Ficjan A, Datz C, Axman R, Zwerina J.

Arthritis Res Ther. 2017 Oct 24;19(1):243. doi: 10.1186/s13075-017-1448-0.

17.

Type 4B hereditary hemochromatosis associated with a novel mutation in the SLC40A1 gene: A case report and a review of the literature.

Zhang W, Lv T, Huang J, Ou X.

Medicine (Baltimore). 2017 Sep;96(38):e8064. doi: 10.1097/MD.0000000000008064. Review.

18.
19.

Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients.

Le Tertre M, Ka C, Guellec J, Gourlaouen I, Férec C, Callebaut I, Le Gac G.

Transfus Clin Biol. 2017 Nov;24(4):462-467. doi: 10.1016/j.tracli.2017.07.002. Epub 2017 Aug 18.

PMID:
28826751
20.

Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants.

Barton JC, Barton JC, Adams PC.

Ann Hepatol. 2017 Sep-Oct;16(5):802-811. doi: 10.5604/01.3001.0010.2815.

Supplemental Content

Loading ...
Support Center